Kontafarma China Holdings Ltd Financial Overview
Kontafarma China Holdings Ltd's market cap is currently HK$156.20M. The company's EPS TTM is HK$-0.051; its P/E ratio is -0.43; Kontafarma China Holdings Ltd is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
